Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development.
Saved in:
| Title: | Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development. |
|---|---|
| Authors: | Liang M; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043., Schwickart M; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043., Schneider AK; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043., Vainshtein I; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043., Del Nagro C; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043., Standifer N; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043., Roskos LK; Department of Clinical Pharmacology and DMPK, Medimmune, LLC, Mountain View, California, 94043. |
| Source: | Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2016 Mar; Vol. 90 (2), pp. 117-27. Date of Electronic Publication: 2015 Jul 31. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4957 (Electronic) Linking ISSN: 15524949 NLM ISO Abbreviation: Cytometry B Clin Cytom Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
